Galecto, Inc.

Unregistered Sales of Equity Securities. On December 31, 2025, in accordance with that certain antibody discovery and option agreement by and among Galecto, Inc

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 6,

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 4.1 Warrant to Purchase Common Stock, dated December 31, 2025 10.1 Offer Letter, date